Genetic variation analysis pointed out that the mutation frequency of PDE4DIP was higher in endometrial cancer, bladder cancer, melanoma, non-small cell lung cancer (NSCLC), hepatobiliary cancer, and BRCA, and the main types included mutation and amplification (Figure S1). This evidence concerns the gene PDE4DIP and non-small cell lung carcinoma.